6Morozumi M, Hasegawa K, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA genc mutation. Antimi- crob Agents C hemother[ J ]. 2005,49 (6) :2302 - 2306.
7Daxboeck F, Blacky A, Seidl R, et al. Diagnosis, treatment, and prognosis of Mycoplasma pneumoniae childhood encephalitis: sys- tematic review of 58 cases [ J ]. J Child Neurol, 2004, 19 ( 11 ) :865 - 871.
8Ozaki T, Nishimura N, Ahn J, et al. Utility of a rapid diagnosis kit for Mycoplasma pneumoniae pneumonia in children, and the antimi- crobial susceptibility of the isolates[ J]. J Infect Chemother, 2007, 13(4) :204 -207.
9Okada T, Momzumi M, Tajima T, et al. Rapid Effectiveness of Mi- nocycline or Doxycycline Against Macrolide-Resistant Mycoplasma pneumoniae Infection in a 2011 Outbreak Among Japanese Children [J]. Clin Infect Dis, 2012, 9(2) :231 -235.
10Kawai Y, Miyashita N, Yamaguchi T, et al. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resist-ant Mycoplasma pneumoniae pneumonia in paediatric patients [ J]. Respirology, 2012, 17(2) :354 -362.
